These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3366175

  • 1. Post- and presynaptic effects of vesamicol (AH5183) on the frog neuromuscular junction.
    Enomoto K.
    Eur J Pharmacol; 1988 Mar 01; 147(2):209-15. PubMed ID: 3366175
    [Abstract] [Full Text] [Related]

  • 2. The effects of L-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction.
    Searl T, Prior C, Marshall IG.
    Neuroscience; 1990 Mar 01; 35(1):145-56. PubMed ID: 2141672
    [Abstract] [Full Text] [Related]

  • 3. A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity.
    Estrella D, Green KL, Prior C, Dempster J, Halliwell RF, Jacobs RS, Parsons SM, Parsons RL, Marshall IG.
    Br J Pharmacol; 1988 Apr 01; 93(4):759-68. PubMed ID: 3260527
    [Abstract] [Full Text] [Related]

  • 4. Reduction of quantal size by vesamicol (AH5183), an inhibitor of vesicular acetylcholine storage.
    Whitton PS, Marshall IG, Parsons SM.
    Brain Res; 1986 Oct 15; 385(1):189-92. PubMed ID: 3768717
    [Abstract] [Full Text] [Related]

  • 5. In favour of the vesicular hypothesis: neurochemical evidence that vesamicol (AH5183) inhibits stimulation-evoked release of acetylcholine from neuromuscular junction.
    Vizi ES.
    Br J Pharmacol; 1989 Nov 15; 98(3):898-902. PubMed ID: 2590773
    [Abstract] [Full Text] [Related]

  • 6. Effects of an inhibitor of the synaptic vesicle acetylcholine transport system on quantal neurotransmitter release: an electrophysiological study.
    Lupa MT.
    Brain Res; 1988 Sep 27; 461(1):118-26. PubMed ID: 3265645
    [Abstract] [Full Text] [Related]

  • 7. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP, Van der Kloot W.
    J Physiol; 1991 Feb 27; 433():677-704. PubMed ID: 1841963
    [Abstract] [Full Text] [Related]

  • 8. Effects of 2-(4-phenylpiperidino)cyclohexanol (AH5183) and barium ions on frog neuromuscular transmission.
    Maeno T, Shibuya Y.
    J Physiol; 1988 Jul 27; 401():671-85. PubMed ID: 2845067
    [Abstract] [Full Text] [Related]

  • 9. 2-(4-phenylpiperidino) cyclohexanol (AH5183) decreases quantal size at the frog neuromuscular junction.
    Van der Kloot W.
    Pflugers Arch; 1986 Jan 27; 406(1):83-5. PubMed ID: 3005958
    [Abstract] [Full Text] [Related]

  • 10. Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium.
    Searl T, Prior C, Marshall IG.
    J Physiol; 1991 Dec 27; 444():99-116. PubMed ID: 1668355
    [Abstract] [Full Text] [Related]

  • 11. Chemical modification of vesamicol binding sites and frequency augmentation-potentiation in neuromuscular transmission.
    Maeno T, Enomoto K, Sawada M, Ichinose M.
    Jpn J Physiol; 1994 Dec 27; 44(6):705-16. PubMed ID: 7760524
    [Abstract] [Full Text] [Related]

  • 12. Physiological and regenerative acetylcholine release from motor nerve: differential inhibitions by vesamicol and omega-agatoxin IVA.
    Hong SJ, Lee SH, Chang CC.
    Neuroscience; 1995 Jul 27; 67(1):169-75. PubMed ID: 7477897
    [Abstract] [Full Text] [Related]

  • 13. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
    Naves LA, Van der Kloot W.
    J Physiol; 2001 May 01; 532(Pt 3):637-47. PubMed ID: 11313435
    [Abstract] [Full Text] [Related]

  • 14. The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions.
    Pemberton KE, Prior C, Marshall IG.
    Br J Pharmacol; 1992 Jan 01; 105(1):113-8. PubMed ID: 1375854
    [Abstract] [Full Text] [Related]

  • 15. Acetylcholine synthesis by a sympathetic ganglion in the presence of 2-(4-phenylpiperidino)cyclohexanol (AH5183) and picrylsulfonic acid.
    Mykita S, Collier B.
    J Neurochem; 1989 Jun 01; 52(6):1686-93. PubMed ID: 2723629
    [Abstract] [Full Text] [Related]

  • 16. Effects of vesicular acetylcholine uptake blockers on frequency augmentation-potentiation in frog neuromuscular transmission.
    Maeno T, Enomoto K.
    Neuroscience; 1994 Mar 01; 59(2):487-93. PubMed ID: 8008203
    [Abstract] [Full Text] [Related]

  • 17. Transmitter packaging at frog neuromuscular junctions exposed to anticholinesterases; the role of second-stage acetylcholine loading.
    Naves LA, Van der Kloot W.
    J Neurophysiol; 1996 Oct 01; 76(4):2614-25. PubMed ID: 8899632
    [Abstract] [Full Text] [Related]

  • 18. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J, del Pozo E, Baños JE, Angaut-Petit D.
    Br J Pharmacol; 1991 Sep 01; 104(1):133-8. PubMed ID: 1686201
    [Abstract] [Full Text] [Related]

  • 19. Propranolol, a curariform and cholinomimetic agent at the frog neuromuscular junction.
    Werman R, Wislicki L.
    Comp Gen Pharmacol; 1971 Mar 01; 2(5):69-81. PubMed ID: 4269641
    [No Abstract] [Full Text] [Related]

  • 20. Presynaptic and postsynaptic depressant effects of phenytoin sodium at the neuromuscular junction.
    Gage PW, Lonergan M, Torda TA.
    Br J Pharmacol; 1980 May 01; 69(1):119-21. PubMed ID: 6247003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.